Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Fosciclopirox by CicloMed for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
Fosciclopirox is under clinical development by CicloMed and currently in Phase I for Transitional Cell Carcinoma (Urothelial Cell Carcinoma). According...